Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSIW) Preferred Dividend Payments (2023 - 2025)

TriSalus Life Sciences' Preferred Dividend Payments history spans 3 years, with the latest figure at $11.9 million for Q3 2025.

  • For Q3 2025, Preferred Dividend Payments changed N/A year-over-year to $11.9 million; the TTM value through Dec 2025 reached $13.4 million, up 734.77%, while the annual FY2025 figure was $11.9 million, N/A changed from the prior year.
  • Preferred Dividend Payments reached $11.9 million in Q3 2025 per TLSIW's latest filing, up from $714000.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $11.9 million in Q3 2025 to a low of $458000.0 in Q3 2023.
  • Average Preferred Dividend Payments over 3 years is $2.3 million, with a median of $800000.0 recorded in 2023.
  • The largest YoY upside for Preferred Dividend Payments was 10.86% in 2025 against a maximum downside of 11.11% in 2025.
  • A 3-year view of Preferred Dividend Payments shows it stood at $800000.0 in 2023, then rose by 0.12% to $801000.0 in 2024, then surged by 1391.51% to $11.9 million in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Preferred Dividend Payments are $11.9 million (Q3 2025), $714000.0 (Q2 2025), and $712000.0 (Q1 2025).